AZN icon

AstraZeneca

89.09 USD
+1.61
1.84%
At close Updated Nov 11, 4:00 PM EST
Pre-market
After hours
89.09
0.00
0%
1 day
1.84%
5 days
9.47%
1 month
5.42%
3 months
20.28%
6 months
29.21%
Year to date
35.23%
1 year
37.51%
5 years
53.55%
10 years
179.81%
 

About: A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Employees: 94,300

0
Funds holding %
of 7,512 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™